1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Dopamine Agonists 1.2.3 Levodopa 1.2.4 Glutamate Antagonist 1.2.5 Apomorphine 1.2.6 COMT Inhibitors Anticholinergics 1.2.7 MAO-B Inhibitors 1.2.8 Other Drugs 1.3 Market by Application 1.3.1 Global Parkinson's Disease Treatments Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Healthcare Institutes 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Parkinson's Disease Treatments Market Perspective (2016-2027) 2.2 Parkinson's Disease Treatments Growth Trends by Regions 2.2.1 Parkinson's Disease Treatments Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Parkinson's Disease Treatments Historic Market Share by Regions (2016-2021) 2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Regions (2022-2027) 2.3 Parkinson's Disease Treatments Industry Dynamic 2.3.1 Parkinson's Disease Treatments Market Trends 2.3.2 Parkinson's Disease Treatments Market Drivers 2.3.3 Parkinson's Disease Treatments Market Challenges 2.3.4 Parkinson's Disease Treatments Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Parkinson's Disease Treatments Players by Revenue 3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2016-2021) 3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2016-2021) 3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue 3.4 Global Parkinson's Disease Treatments Market Concentration Ratio 3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2020 3.5 Parkinson's Disease Treatments Key Players Head office and Area Served 3.6 Key Players Parkinson's Disease Treatments Product Solution and Service 3.7 Date of Enter into Parkinson's Disease Treatments Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Parkinson's Disease Treatments Breakdown Data by Type 4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2016-2021) 4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2022-2027) 5 Parkinson's Disease Treatments Breakdown Data by Application 5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2016-2021) 5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Parkinson's Disease Treatments Market Size (2016-2027) 6.2 North America Parkinson's Disease Treatments Market Size by Type 6.2.1 North America Parkinson's Disease Treatments Market Size by Type (2016-2021) 6.2.2 North America Parkinson's Disease Treatments Market Size by Type (2022-2027) 6.2.3 North America Parkinson's Disease Treatments Market Size by Type (2016-2027) 6.3 North America Parkinson's Disease Treatments Market Size by Application 6.3.1 North America Parkinson's Disease Treatments Market Size by Application (2016-2021) 6.3.2 North America Parkinson's Disease Treatments Market Size by Application (2022-2027) 6.3.3 North America Parkinson's Disease Treatments Market Size by Application (2016-2027) 6.4 North America Parkinson's Disease Treatments Market Size by Country 6.4.1 North America Parkinson's Disease Treatments Market Size by Country (2016-2021) 6.4.2 North America Parkinson's Disease Treatments Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Parkinson's Disease Treatments Market Size (2016-2027) 7.2 Europe Parkinson's Disease Treatments Market Size by Type 7.2.1 Europe Parkinson's Disease Treatments Market Size by Type (2016-2021) 7.2.2 Europe Parkinson's Disease Treatments Market Size by Type (2022-2027) 7.2.3 Europe Parkinson's Disease Treatments Market Size by Type (2016-2027) 7.3 Europe Parkinson's Disease Treatments Market Size by Application 7.3.1 Europe Parkinson's Disease Treatments Market Size by Application (2016-2021) 7.3.2 Europe Parkinson's Disease Treatments Market Size by Application (2022-2027) 7.3.3 Europe Parkinson's Disease Treatments Market Size by Application (2016-2027) 7.4 Europe Parkinson's Disease Treatments Market Size by Country 7.4.1 Europe Parkinson's Disease Treatments Market Size by Country (2016-2021) 7.4.2 Europe Parkinson's Disease Treatments Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Parkinson's Disease Treatments Market Size (2016-2027) 8.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type 8.2.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2016-2027) 8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Application 8.3.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2016-2027) 8.4 Asia-Pacific Parkinson's Disease Treatments Market Size by Region 8.4.1 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Parkinson's Disease Treatments Market Size (2016-2027) 9.2 Latin America Parkinson's Disease Treatments Market Size by Type 9.2.1 Latin America Parkinson's Disease Treatments Market Size by Type (2016-2021) 9.2.2 Latin America Parkinson's Disease Treatments Market Size by Type (2022-2027) 9.2.3 Latin America Parkinson's Disease Treatments Market Size by Type (2016-2027) 9.3 Latin America Parkinson's Disease Treatments Market Size by Application 9.3.1 Latin America Parkinson's Disease Treatments Market Size by Application (2016-2021) 9.3.2 Latin America Parkinson's Disease Treatments Market Size by Application (2022-2027) 9.3.3 Latin America Parkinson's Disease Treatments Market Size by Application (2016-2027) 9.4 Latin America Parkinson's Disease Treatments Market Size by Country 9.4.1 Latin America Parkinson's Disease Treatments Market Size by Country (2016-2021) 9.4.2 Latin America Parkinson's Disease Treatments Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Parkinson's Disease Treatments Market Size (2016-2027) 10.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type 10.2.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2016-2027) 10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application 10.3.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2016-2027) 10.4 Middle East & Africa Parkinson's Disease Treatments Market Size by Country 10.4.1 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GSK 11.1.1 GSK Company Details 11.1.2 GSK Business Overview 11.1.3 GSK Parkinson's Disease Treatments Introduction 11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.1.5 GSK Recent Development 11.2 Merck 11.2.1 Merck Company Details 11.2.2 Merck Business Overview 11.2.3 Merck Parkinson's Disease Treatments Introduction 11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.2.5 Merck Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Parkinson's Disease Treatments Introduction 11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Teva 11.4.1 Teva Company Details 11.4.2 Teva Business Overview 11.4.3 Teva Parkinson's Disease Treatments Introduction 11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.4.5 Teva Recent Development 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Details 11.5.2 Boehringer Ingelheim Business Overview 11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction 11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.5.5 Boehringer Ingelheim Recent Development 11.6 Impax 11.6.1 Impax Company Details 11.6.2 Impax Business Overview 11.6.3 Impax Parkinson's Disease Treatments Introduction 11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.6.5 Impax Recent Development 11.7 Abbvie 11.7.1 Abbvie Company Details 11.7.2 Abbvie Business Overview 11.7.3 Abbvie Parkinson's Disease Treatments Introduction 11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.7.5 Abbvie Recent Development 11.8 Bausch Health 11.8.1 Bausch Health Company Details 11.8.2 Bausch Health Business Overview 11.8.3 Bausch Health Parkinson's Disease Treatments Introduction 11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.8.5 Bausch Health Recent Development 11.9 Lundbeck 11.9.1 Lundbeck Company Details 11.9.2 Lundbeck Business Overview 11.9.3 Lundbeck Parkinson's Disease Treatments Introduction 11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.9.5 Lundbeck Recent Development 11.10 Sun Pharma 11.10.1 Sun Pharma Company Details 11.10.2 Sun Pharma Business Overview 11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction 11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.10.5 Sun Pharma Recent Development 11.11 Wockhardt 11.11.1 Wockhardt Company Details 11.11.2 Wockhardt Business Overview 11.11.3 Wockhardt Parkinson's Disease Treatments Introduction 11.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.11.5 Wockhardt Recent Development 11.12 Acadia 11.12.1 Acadia Company Details 11.12.2 Acadia Business Overview 11.12.3 Acadia Parkinson's Disease Treatments Introduction 11.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.12.5 Acadia Recent Development 11.13 UCB 11.13.1 UCB Company Details 11.13.2 UCB Business Overview 11.13.3 UCB Parkinson's Disease Treatments Introduction 11.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2016-2021) 11.13.5 UCB Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Parkinson's Disease Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Dopamine Agonists Table 3. Key Players of Levodopa Table 4. Key Players of Glutamate Antagonist Table 5. Key Players of Apomorphine Table 6. Key Players of COMT Inhibitors Anticholinergics Table 7. Key Players of MAO-B Inhibitors Table 8. Key Players of Other Drugs Table 9. Global Parkinson's Disease Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Parkinson's Disease Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Parkinson's Disease Treatments Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Parkinson's Disease Treatments Market Share by Regions (2016-2021) Table 13. Global Parkinson's Disease Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Parkinson's Disease Treatments Market Share by Regions (2022-2027) Table 15. Parkinson's Disease Treatments Market Trends Table 16. Parkinson's Disease Treatments Market Drivers Table 17. Parkinson's Disease Treatments Market Challenges Table 18. Parkinson's Disease Treatments Market Restraints Table 19. Global Parkinson's Disease Treatments Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Parkinson's Disease Treatments Market Share by Players (2016-2021) Table 21. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Treatments as of 2020) Table 22. Ranking of Global Top Parkinson's Disease Treatments Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Parkinson's Disease Treatments Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Parkinson's Disease Treatments Product Solution and Service Table 26. Date of Enter into Parkinson's Disease Treatments Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 29. Global Parkinson's Disease Treatments Revenue Market Share by Type (2016-2021) Table 30. Global Parkinson's Disease Treatments Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Parkinson's Disease Treatments Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Parkinson's Disease Treatments Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Parkinson's Disease Treatments Revenue Market Share by Application (2016-2021) Table 34. Global Parkinson's Disease Treatments Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Parkinson's Disease Treatments Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 37. North America Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 39. North America Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Parkinson's Disease Treatments Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Parkinson's Disease Treatments Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2022-2027) & (US$ Million) Table 66. GSK Company Details Table 67. GSK Business Overview Table 68. GSK Parkinson's Disease Treatments Product Table 69. GSK Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 70. GSK Recent Development Table 71. Merck Company Details Table 72. Merck Business Overview Table 73. Merck Parkinson's Disease Treatments Product Table 74. Merck Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 75. Merck Recent Development Table 76. Novartis Company Details Table 77. Novartis Business Overview Table 78. Novartis Parkinson's Disease Treatments Product Table 79. Novartis Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 80. Novartis Recent Development Table 81. Teva Company Details Table 82. Teva Business Overview Table 83. Teva Parkinson's Disease Treatments Product Table 84. Teva Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 85. Teva Recent Development Table 86. Boehringer Ingelheim Company Details Table 87. Boehringer Ingelheim Business Overview Table 88. Boehringer Ingelheim Parkinson's Disease Treatments Product Table 89. Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 90. Boehringer Ingelheim Recent Development Table 91. Impax Company Details Table 92. Impax Business Overview Table 93. Impax Parkinson's Disease Treatments Product Table 94. Impax Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 95. Impax Recent Development Table 96. Abbvie Company Details Table 97. Abbvie Business Overview Table 98. Abbvie Parkinson's Disease Treatments Product Table 99. Abbvie Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 100. Abbvie Recent Development Table 101. Bausch Health Company Details Table 102. Bausch Health Business Overview Table 103. Bausch Health Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 104. Bausch Health Recent Development Table 105. Lundbeck Company Details Table 106. Lundbeck Business Overview Table 107. Lundbeck Parkinson's Disease Treatments Product Table 108. Lundbeck Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 109. Lundbeck Recent Development Table 110. Sun Pharma Company Details Table 111. Sun Pharma Business Overview Table 112. Sun Pharma Parkinson's Disease Treatments Product Table 113. Sun Pharma Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 114. Sun Pharma Recent Development Table 115. Wockhardt Company Details Table 116. Wockhardt Business Overview Table 117. Wockhardt Parkinson's Disease Treatments Product Table 118. Wockhardt Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 119. Wockhardt Recent Development Table 120. Acadia Company Details Table 121. Acadia Business Overview Table 122. Acadia Parkinson's Disease Treatments Product Table 123. Acadia Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 124. Acadia Recent Development Table 125. UCB Company Details Table 126. UCB Business Overview Table 127. UCB Parkinson's Disease Treatments Product Table 128. UCB Revenue in Parkinson's Disease Treatments Business (2016-2021) & (US$ Million) Table 129. UCB Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Parkinson's Disease Treatments Market Share by Type: 2020 VS 2027 Figure 2. Dopamine Agonists Features Figure 3. Levodopa Features Figure 4. Glutamate Antagonist Features Figure 5. Apomorphine Features Figure 6. COMT Inhibitors Anticholinergics Features Figure 7. MAO-B Inhibitors Features Figure 8. Other Drugs Features Figure 9. Global Parkinson's Disease Treatments Market Share by Application: 2020 VS 2027 Figure 10. Hospitals Case Studies Figure 11. Healthcare Institutes Case Studies Figure 12. Others Case Studies Figure 13. Parkinson's Disease Treatments Report Years Considered Figure 14. Global Parkinson's Disease Treatments Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Parkinson's Disease Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Parkinson's Disease Treatments Market Share by Regions: 2020 VS 2027 Figure 17. Global Parkinson's Disease Treatments Market Share by Regions (2022-2027) Figure 18. Global Parkinson's Disease Treatments Market Share by Players in 2020 Figure 19. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Treatments as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatments Revenue in 2020 Figure 21. Global Parkinson's Disease Treatments Revenue Market Share by Type (2016-2021) Figure 22. Global Parkinson's Disease Treatments Revenue Market Share by Type (2022-2027) Figure 23. North America Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Parkinson's Disease Treatments Market Share by Type (2016-2027) Figure 25. North America Parkinson's Disease Treatments Market Share by Application (2016-2027) Figure 26. North America Parkinson's Disease Treatments Market Share by Country (2016-2027) Figure 27. United States Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Parkinson's Disease Treatments Market Share by Type (2016-2027) Figure 31. Europe Parkinson's Disease Treatments Market Share by Application (2016-2027) Figure 32. Europe Parkinson's Disease Treatments Market Share by Country (2016-2027) Figure 33. Germany Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Parkinson's Disease Treatments Market Share by Type (2016-2027) Figure 41. Asia-Pacific Parkinson's Disease Treatments Market Share by Application (2016-2027) Figure 42. Asia-Pacific Parkinson's Disease Treatments Market Share by Region (2016-2027) Figure 43. China Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Parkinson's Disease Treatments Market Share by Type (2016-2027) Figure 51. Latin America Parkinson's Disease Treatments Market Share by Application (2016-2027) Figure 52. Latin America Parkinson's Disease Treatments Market Share by Country (2016-2027) Figure 53. Mexico Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Parkinson's Disease Treatments Market Share by Type (2016-2027) Figure 57. Middle East & Africa Parkinson's Disease Treatments Market Share by Application (2016-2027) Figure 58. Middle East & Africa Parkinson's Disease Treatments Market Share by Country (2016-2027) Figure 59. Turkey Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Parkinson's Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. GSK Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 63. Merck Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 64. Novartis Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 65. Teva Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 66. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 67. Impax Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 68. Abbvie Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 69. Bausch Health Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 70. Lundbeck Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 71. Sun Pharma Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 72. Wockhardt Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 73. Acadia Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 74. UCB Revenue Growth Rate in Parkinson's Disease Treatments Business (2016-2021) Figure 75. Bottom-up and Top-down Approaches for This Report Figure 76. Data Triangulation Figure 77. Key Executives Interviewed

GSK Merck Novartis Teva Boehringer Ingelheim Impax Abbvie Bausch Health Lundbeck Sun Pharma Wockhardt Acadia UCB